FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2134888445> ?p ?o ?g. }

• W2134888445 endingPage "596" @default.
• W2134888445 startingPage "587" @default.
• W2134888445 abstract "Bone is a frequent target of lung cancer metastasis, which is associated with significant morbidity and a dismal prognosis. This study analyzed the soluble factors secreted by lung cancer cells, which are responsible for increasing osteoclast differentiation. Addition of recombinant human interleukin-8 (rhIL-8), present in large amounts in A549-conditioned medium (CM) and NCI-H460-CM, mimicked the inductive effect of A549-CM and NCI-H460-CM on osteoclastogenesis. In contrast, depletion of interleukin-8 (IL-8) from A549-CM and NCI-H460-CM decreased the osteoclastogenesis-inductive properties of A549-CM and NCI-H460-CM. Induction of osteoclast differentiation by lung cancer-derived-CM and rhIL-8 was associated with increased phospholipase D (PLD) activation, and the activations of protein kinase C (PKC) α/βII, extracellular signal-regulated kinase (ERK) 1/2 and AKT/the mammalian target of rapamycin (mTOR). Blocking PLD by a specific inhibitor significantly decreased osteoclast formation by inhibiting PKCs activation and subsequently attenuating the phosphorylation of ERK1/2. PLD inhibitor also completely decreased AKT and mTOR phosphorylation, whereas phosphatidylinositol-3-kinase (PI3K) inhibitor only partially decreased mTOR phosphorylation, suggesting that mTOR activation by PLD is through both PI3K/AKT-dependent and PI3K/AKT-independent manner. In addition, blocking AKT and ERK1/2 by a specific inhibitor also suppressed lung cancer-derived-CM and rhIL-8-induced osteoclast differentiation. Moreover, treatment of peripheral blood mononuclear cells with sera from invasive lung cancer patients increased the formation of osteoclasts. Our study suggests that IL-8 or IL-8-mediated PLD/PKC/ERK1/2 or PLD/AKT signaling is an attractive therapeutic target for osteolytic bone metastases in lung cancer patients." @default.
• W2134888445 created "2016-06-24" @default.
• W2134888445 creator A5061928130 @default.
• W2134888445 creator A5062968118 @default.
• W2134888445 creator A5072563983 @default.
• W2134888445 creator A5073269098 @default.
• W2134888445 creator A5073595206 @default.
• W2134888445 creator A5074411104 @default.
• W2134888445 date "2010-01-27" @default.
• W2134888445 modified "2023-10-16" @default.
• W2134888445 title "Phospholipase D signaling pathway is involved in lung cancer-derived IL-8 increased osteoclastogenesis" @default.
• W2134888445 cites W1511948457 @default.
• W2134888445 cites W1527082449 @default.
• W2134888445 cites W1530292017 @default.
• W2134888445 cites W1607293794 @default.
• W2134888445 cites W1966908666 @default.
• W2134888445 cites W1971535810 @default.
• W2134888445 cites W1971733850 @default.
• W2134888445 cites W1980814667 @default.
• W2134888445 cites W1986854615 @default.
• W2134888445 cites W1994377649 @default.
• W2134888445 cites W1999587233 @default.
• W2134888445 cites W2019364582 @default.
• W2134888445 cites W2023245305 @default.
• W2134888445 cites W2023962715 @default.
• W2134888445 cites W2031162487 @default.
• W2134888445 cites W2040653256 @default.
• W2134888445 cites W2046618178 @default.
• W2134888445 cites W2052871249 @default.
• W2134888445 cites W2053339285 @default.
• W2134888445 cites W2059086985 @default.
• W2134888445 cites W2060870390 @default.
• W2134888445 cites W2095349122 @default.
• W2134888445 cites W2096806896 @default.
• W2134888445 cites W2109504086 @default.
• W2134888445 cites W2110567472 @default.
• W2134888445 cites W2111419867 @default.
• W2134888445 cites W2116913977 @default.
• W2134888445 cites W2127114287 @default.
• W2134888445 cites W2129084462 @default.
• W2134888445 cites W2129552339 @default.
• W2134888445 cites W2130593277 @default.
• W2134888445 cites W2139483234 @default.
• W2134888445 cites W2140035585 @default.
• W2134888445 cites W2149584534 @default.
• W2134888445 cites W2149783480 @default.
• W2134888445 cites W2155894543 @default.
• W2134888445 cites W2158945729 @default.
• W2134888445 cites W2171262890 @default.
• W2134888445 cites W2419338341 @default.
• W2134888445 cites W310140967 @default.
• W2134888445 doi "https://doi.org/10.1093/carcin/bgq030" @default.
• W2134888445 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20106902" @default.
• W2134888445 hasPublicationYear "2010" @default.
• W2134888445 type Work @default.
• W2134888445 sameAs 2134888445 @default.
• W2134888445 citedByCount "48" @default.
• W2134888445 countsByYear W21348884452012 @default.
• W2134888445 countsByYear W21348884452013 @default.
• W2134888445 countsByYear W21348884452014 @default.
• W2134888445 countsByYear W21348884452015 @default.
• W2134888445 countsByYear W21348884452016 @default.
• W2134888445 countsByYear W21348884452017 @default.
• W2134888445 countsByYear W21348884452018 @default.
• W2134888445 countsByYear W21348884452019 @default.
• W2134888445 countsByYear W21348884452020 @default.
• W2134888445 countsByYear W21348884452021 @default.
• W2134888445 countsByYear W21348884452022 @default.
• W2134888445 countsByYear W21348884452023 @default.
• W2134888445 crossrefType "journal-article" @default.
• W2134888445 hasAuthorship W2134888445A5061928130 @default.
• W2134888445 hasAuthorship W2134888445A5062968118 @default.
• W2134888445 hasAuthorship W2134888445A5072563983 @default.
• W2134888445 hasAuthorship W2134888445A5073269098 @default.
• W2134888445 hasAuthorship W2134888445A5073595206 @default.
• W2134888445 hasAuthorship W2134888445A5074411104 @default.
• W2134888445 hasBestOaLocation W21348884451 @default.
• W2134888445 hasConcept C11960822 @default.
• W2134888445 hasConcept C126322002 @default.
• W2134888445 hasConcept C170493617 @default.
• W2134888445 hasConcept C184235292 @default.
• W2134888445 hasConcept C185592680 @default.
• W2134888445 hasConcept C2776033226 @default.
• W2134888445 hasConcept C2776256026 @default.
• W2134888445 hasConcept C502942594 @default.
• W2134888445 hasConcept C55493867 @default.
• W2134888445 hasConcept C57074206 @default.
• W2134888445 hasConcept C6182249 @default.
• W2134888445 hasConcept C62478195 @default.
• W2134888445 hasConcept C71924100 @default.
• W2134888445 hasConcept C75217442 @default.
• W2134888445 hasConcept C81729549 @default.
• W2134888445 hasConcept C86554907 @default.
• W2134888445 hasConcept C86803240 @default.
• W2134888445 hasConcept C95444343 @default.
• W2134888445 hasConceptScore W2134888445C11960822 @default.
• W2134888445 hasConceptScore W2134888445C126322002 @default.
• W2134888445 hasConceptScore W2134888445C170493617 @default.

• next